Drug

Echinacea (angustifolia), Tabebuia Impetiginosa, Hydrastis Canadensis, Glandula Suprarenalis Suis, Thymus (suis), Thyroidinum (suis), Arsenicum Album, Bryonia (alba), Cocculus Indicus, Colchicum Autumnale, Ledum Palustre, Mercurius Cyanatus, Natrum Sulphuricum, Pulsatilla (pratensis), Sepia, Silicea, Aflatoxin (b1)

20 flagged reaction(s) · 689 total co-reports · max PRR 116.6

Important: Reactions below are the flagged terms from this drug’s FAERS report history (min. 3 co-reports per term) — PRR/ROR indicate disproportionality in spontaneous reporting, not causation. Data from FDA FAERS via openFDA. Last recalculated: 2026-09-14.

	Reaction	Co-reports (a)	PRR	ROR	Signal
1	Acute Myeloid Leukaemia	61	116.6	127.6	signal
2	Febrile Neutropenia	153	68.7	87.4	signal
3	Myelosuppression	65	56.8	62.4	signal
4	Hepatic Function Abnormal	68	54.5	60.2	signal
5	Neutrophil Count Decreased	45	33.0	35.2	signal
6	Bone Marrow Failure	21	30.5	31.4	signal
7	Cytopenia	11	27.3	27.7	signal
8	Platelet Count Decreased	91	25.4	29.0	signal
9	Blood Lactate Dehydrogenase Increased	13	24.2	24.6	signal
10	Electrocardiogram Qt Prolonged	26	21.4	22.2	signal
11	Liver Disorder	32	21.4	22.4	signal
12	Disseminated Intravascular Coagulation	10	21.0	21.3	signal
13	Bacteraemia	8	20.2	20.4	signal
14	Blood Creatine Phosphokinase Increased	16	16.2	16.6	signal
15	Skin Infection	6	16.0	16.1	signal
16	Ejection Fraction Decreased	7	13.3	13.5	signal
17	Posterior Reversible Encephalopathy Syndrome	4	12.5	12.5	signal
18	Thrombotic Microangiopathy	4	12.3	12.3	signal
19	White Blood Cell Count Decreased	42	11.5	12.1	signal
20	Cytomegalovirus Infection	6	10.7	10.8	signal